Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
III期可切除非小细胞肺癌患者围手术期接受纳武利尤单抗治疗的临床结局与淋巴结状态的关系：CheckMate 77T III期探索性分析
期刊:Nature Cancer
影响因子:28.5
doi:10.1038/s43018-025-01104-z
Provencio, Mariano; Awad, Mark M; Spicer, Jonathan D; Janssens, Annelies; Moiseyenko, Fedor; Gao, Yang; Watanabe, Yasutaka; Alexandru, Aurelia; Guisier, Florian; Frost, Nikolaj; Franke, Fabio; Hiltermann, T Jeroen Nicolaas; He, Jie; Tanaka, Fumihiro; Lu, Shun; Coronado Erdmann, Cinthya; Sathyanarayana, Padma; Tran, Phuong; Devas, Vipul; Cascone, Tina
